Skip to main content
VISIT JANSSEN GLOBAL
 
 
 

HONG KONG
change location▼

Search
COVID-19 UPDATED >

Welcome to Janssen Hong Kong

VISIT JANSSEN GLOBAL

COVID-19 UPDATED >

Our Focus

Michelle Hammer, Silence, Surgical. A New York City native living with schizophrenia, Michelle uses her talents to reduce stigma and start conversations about mental health

Our Focus

Michelle Hammer, Silence, Surgical. A New York City native living with schizophrenia, Michelle uses her talents to reduce stigma and start conversations about mental health

Title

Our Focus

We focus our efforts and resources where the need is high, the science is compelling and where we have the greatest opportunity to save and improve lives. This is why we are focused on pushing the boundaries of medicine, to help resolve some of the most challenging medical conditions of our time.

 
 

Neuroscience

One in four people globally will be affected by a neurological or mental disorder at some stage in life. At Janssen, our history is tied to neuroscience. We have a legacy of more than 50 years developing treatments for mental illnesses.

 

 

 
 

Oncology

Cancer is one of the most debilitating diseases known to humankind. At Janssen, our work in the oncology space spans more than 30 years. This is reflected in our legacy of delivering transformational medicines that redefine the standard of care for our patients.

 

 

 
 

Immunology

Every day, millions of people around the world are challenged by diseases that are caused by an overreactive immune system. At Janssen, we are constantly searching for new ways to restore immune balance and improve the lives these patients.

 

 

 
 

Infections Diseases and Vaccines

Infectious diseases have a devastating impact on human health. At Janssen, we are leveraging our strong foundations in science and technology to develop medicines and vaccines that can prevent, treat and, ultimately, cure some of the world’s deadliest infectious diseases, such as HIV and TB.

 

 

 
 

Cardiovascular and Metabolism

Cardiovascular disease is the leading cause of death in the world, and half of all cardiovascular deaths occur in Asia. At Janssen, we are committed to the prevention and treatment of cardiovascular and metabolic diseases. We aim to develop innovative medicines and a comprehensive care approach to improve the lives of millions who are affected by these diseases.

 

 

 
 

Pulmonary Hypertension

Pulmonary hypertension (PH) is raised blood pressure in the arteries delivering blood to the lungs. Heart failure may develop as the condition worsens. Today, our medicines have helped to significantly improve the prognosis and quality of life of people affected by this disease.